What is the appropriate management for a normal umbilical artery Doppler study at 38 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Normal Umbilical Artery Doppler at 38 Weeks Gestation

With a normal umbilical artery Doppler at 38 weeks, proceed with routine prenatal care and plan delivery at 39-40 weeks unless fetal growth restriction is present, in which case deliver at 38-39 weeks. 1, 2

Essential Clinical Context Assessment

Before finalizing your management plan, you must determine whether fetal growth restriction (FGR) is present, as this fundamentally changes the delivery timing even with normal Doppler findings:

If FGR is Present (EFW <10th percentile):

  • Deliver at 38-39 weeks gestation when estimated fetal weight is between the 3rd and 10th percentile with normal umbilical artery Doppler. 1, 2
  • This recommendation applies specifically to FGR with normal Doppler—the normal Doppler does not eliminate the need for earlier delivery when growth restriction exists. 1

If No FGR (Normal Growth):

  • Continue routine prenatal care with delivery planning at 39-40 weeks. 3
  • The normal Doppler at 38 weeks is reassuring and supports expectant management to full term. 3

Critical Additional Assessments Required

Do not rely solely on the Doppler result. Complete the following evaluations to ensure safe expectant management:

  • Amniotic fluid volume assessment using either amniotic fluid index (AFI) or maximum vertical pocket measurement—oligohydramnios (AFI <5 cm) at 38 weeks mandates immediate delivery regardless of normal Doppler. 3, 4
  • Estimated fetal weight to definitively rule out FGR, as even mild growth restriction changes your delivery timing. 3
  • Fetal surveillance with cardiotocography to confirm reassuring fetal status. 2

Surveillance Protocol Until Delivery

For pregnancies with FGR and normal Doppler awaiting delivery at 38-39 weeks:

  • Serial umbilical artery Doppler assessment every 2 weeks to monitor for deterioration. 1, 2
  • Weekly cardiotocography testing after viability for ongoing fetal well-being assessment. 1
  • If Doppler deteriorates to show decreased diastolic flow, deliver immediately at 37+ weeks. 1, 2

Common Pitfalls to Avoid

  • Do not delay delivery beyond 39 weeks if FGR is present, even with normal Doppler—the growth restriction itself increases perinatal risk. 1, 4
  • Do not ignore oligohydramnios at term; severe oligohydramnios (AFI ≤3 cm) combined with any concern for FGR is an independent indication for delivery at 38 weeks. 4
  • Do not assume normal Doppler excludes all risk—FGR with normal Doppler still carries increased risk of intrapartum complications requiring close monitoring during labor. 2, 5
  • Do not use middle cerebral artery, ductus venosus, or uterine artery Doppler for routine clinical management decisions, as these are not recommended for standard FGR management. 1, 2

Mode of Delivery Considerations

With normal umbilical artery Doppler at 38 weeks:

  • Induction of labor is reasonable if FGR is present and you are proceeding with delivery at 38-39 weeks. 4
  • Continuous fetal monitoring during labor is mandatory if FGR is present, as these fetuses remain at higher risk for intrapartum hypoxia despite normal Doppler. 4
  • Cesarean delivery is not routinely indicated based solely on normal Doppler findings—reserve cesarean for standard obstetric indications. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Timing of Delivery for Fetal Growth Restriction (FGR) with Abnormal Dopplers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of 38-Week Pregnancy with Reactive NST Following Decreased Fetal Movement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Intrauterine Growth Restriction at 38 Weeks with Severe Oligohydramnios

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

In a 38‑week pregnant woman with reduced fetal movements, a non‑reactive cardiotocogram, and a lacunar placenta, is a normal umbilical‑artery Doppler sufficient to safely discharge her?
What is a normal umbilical‑cord Doppler pulsatility index at 38 weeks gestation in a fetus without growth restriction?
What is the clinical significance of an elevated pulsatility index in the umbilical vein in a pregnant woman?
Can a 7‑lb weight gain prolong the QT interval?
Why do clinicians avoid iron supplements but prescribe folic acid in patients with thalassemia trait or microcytic anemia when iron studies are normal?
What is the recommended evaluation and management for a patient with sudden headache, dizziness, nausea, confusion, chest pain, or loss of consciousness after possible carbon monoxide exposure in an enclosed space?
How should I manage an 86‑year‑old woman presenting for an annual wellness visit with persistent mixed stress/urge urinary incontinence (including nocturnal leakage) and prior incontinence surgery, a urinalysis positive for nitrites, leukocyte esterase, many white blood cells and many bacteria but no urinary symptoms (asymptomatic bacteriuria), elevated thyroid‑stimulating hormone (TSH) indicating under‑replacement hypothyroidism, hypertension treated with enalapril (ACE inhibitor) with occasional missed doses and mild hyperkalemia, and moderate dyslipidemia (low‑density lipoprotein cholesterol 119 mg/dL)?
How does clonidine alleviate anxiety?
For a 25‑year‑old woman with severe premenstrual syndrome, what key history elements should be obtained and what traditional and complementary treatment options are available?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.